In Vitro Efficacy of Crataegus oxycantha L. (Hawthorn) and Its Major Components against ATCC and Clinical Strains of Ureaplasma urealyticum

Journals Menu

Follow SCIRP

ISSN Print: 2165-3402
ISSN Online: 2165-3410
www.scirp.org/journal/aim
E-mail: aim@scirp.org

"In Vitro Efficacy of Crataegus oxycantha L. (Hawthorn) and Its Major Components against ATCC and Clinical Strains of Ureaplasma urealyticum"
written by Carlo Bisignano, Pio Maria Furneri, Giuseppina Mandalari,
published by Advances in Microbiology, Vol.6 No.12, 2016

has been cited by the following article(s):

[1]	Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma Cells
	2021

[2]	Hawthorn (Crataegus spp.): An Updated Overview on Its Beneficial Properties
	2020

[3]	Phytochemical composition and bioactivities of hawthorn (Crataegus spp.): review of recent research advances
	2018

[4]	Etude bibliographique sur l'Aubépine: Crataegus laevigata Poir (DC)(syn: Crataegus oxyacantha L)
	2017

[1]	Himalayan Fruits and Berries 2023 DOI:10.1016/B978-0-323-85591-4.00040-4

[2]	Genetic Manipulation of Secondary Metabolites in Medicinal Plant Interdisciplinary Biotechnological Advances, 2023 DOI:10.1007/978-981-99-4939-7_8

[3]	Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma Cells Molecules, 2021 DOI:10.3390/molecules26092656

[4]	Hawthorn (Crataegus spp.): An Updated Overview on Its Beneficial Properties Forests, 2020 DOI:10.3390/f11050564

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top